A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa — Stella
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(138 sites) United States
Total Skin and Beauty Dermatology Center PC, Birmingham, Alabama CTT Research, Gilbert, Arizona Ctr Dermatology and Plastic Surgery, Scottsdale, Arizona Ctr for Dermatology Clinical Res, Fremont, California USC Keck School of Medicine, Los Angeles, California MedDerm Associates, San Diego, California Driven Research, Coral Gables, Florida Floridian Research Institute, Miami, Florida Sarasota Arthritis Res Ctr, Sarasota, Florida University Of South Florida, Tampa, Florida Emory School of Med Dermatology, Atlanta, Georgia Atlanta Biomedical Clin Res LLC, Atlanta, Georgia Northwestern University, Chicago, Illinois Endeavor Health, Glenview, Illinois Dundee Dermatology, West Dundee, Illinois Southern IN Clinical Trials, New Albany, Indiana Beth Israel Deaconess Med Center, Boston, Massachusetts Metro Boston Clinical Partners, Brighton, Massachusetts Clinical Research Inst of MI, Chesterfield, Michigan Deluxe Dermatology, St Louis, Missouri Skin Specialists PC, Omaha, Nebraska Vivida Dermatology, Las Vegas, Nevada North Shore University Hospital, New Hyde Park, New York Cameron Dermatology, New York, New York Optima Research Boardman, Boardman, Ohio Ohio State University, Columbus, Ohio Wright State University, Fairborn, Ohio Apex Clinical Research Center LLC, Mayfield Heights, Ohio Clinical Research Ctr of Carolinas, Charleston, South Carolina Goodlettsville Dermatology Research, Goodlettsville, Tennessee Accurate Clinical Research, Humble, Texas Austin Inst for Clinical Research, Pflugerville, Texas Center for Clinical Studies-Lee, Webster, Texas Care Access Alexandria, Arlington, Virginia Complexions Dermatology, Danville, Virginia Forefront Dermatology, Vienna, Virginia Argentina
Novartis Investigative Site, Berazategui, Buenos Aires Novartis Investigative Site, CABA Novartis Investigative Site, Caba Novartis Investigative Site, Córdoba Austria
Novartis Investigative Site, Linz Belgium
Novartis Investigative Site, Brussels, Brussels Capital Novartis Investigative Site, Woluwe-Saint-Lambert, Brussels Capital Novartis Investigative Site, Leuven, Vlaams Brabant Novartis Investigative Site, Liège Canada
Novartis Investigative Site, Edmonton, Alberta Novartis Investigative Site, London, Ontario Novartis Investigative Site, Montreal, Quebec Novartis Investigative Site, Québec, Quebec Novartis Investigative Site, Sherbrooke, Quebec Colombia
Novartis Investigative Site, Medellín, Antioquia Novartis Investigative Site, Bogota, Cundinamarca Novartis Investigative Site, Bogota, Cundinamarca Novartis Investigative Site, Medellín Czechia
Novartis Investigative Site, Karlovy Vary Novartis Investigative Site, Plzen Bolevec Novartis Investigative Site, Prague Novartis Investigative Site, Prague Novartis Investigative Site, Prague Novartis Investigative Site, Prague Novartis Investigative Site, Prague France
Novartis Investigative Site, Brest Novartis Investigative Site, La Rochelle Novartis Investigative Site, Lyon Novartis Investigative Site, Nice Novartis Investigative Site, Reims Novartis Investigative Site, Rouen Novartis Investigative Site, Toulouse Germany
Novartis Investigative Site, Freiburg im Breisgau, Baden-Wurttemberg Novartis Investigative Site, Würzburg, Bavaria Novartis Investigative Site, Frankfurt am Main, Hesse Novartis Investigative Site, Düsseldorf, North Rhine-Westphalia Novartis Investigative Site, Merzig, Saarland Novartis Investigative Site, Leipzig, Saxony Novartis Investigative Site, Bad Bentheim Novartis Investigative Site, Berlin Novartis Investigative Site, Dessau Novartis Investigative Site, Dortmund Novartis Investigative Site, Essen Novartis Investigative Site, Hamburg Novartis Investigative Site, Lübeck Greece
Novartis Investigative Site, Athens Novartis Investigative Site, Chaïdári Novartis Investigative Site, Thessaloniki Hungary
Novartis Investigative Site, Pécs, Baranya Novartis Investigative Site, Debrecen, Hajdu Bihar Megye Novartis Investigative Site, Debrecen, Hajdú-Bihar Novartis Investigative Site, Budapest Novartis Investigative Site, Budapest Novartis Investigative Site, Kecskemét Novartis Investigative Site, Szeged Malaysia
Novartis Investigative Site, Kuala Lumpur, Kuala Lumpur Novartis Investigative Site, Ipoh, Perak Novartis Investigative Site, Kota Kinabalu, Sabah Novartis Investigative Site, Johor Bahru Novartis Investigative Site, Selangor Darul Ehsan Novartis Investigative Site, Wilayah Persekutuan Mexico
Novartis Investigative Site, Monterrey, Nuevo León Novartis Investigative Site, Culiacán, Sinaloa Novartis Investigative Site, Durango Poland
Novartis Investigative Site, Warsaw, Masovian Voivodeship Novartis Investigative Site, Warsaw Novartis Investigative Site, Warsaw Puerto Rico
Alma Cruz-Santana Private Practice, Carolina Romania
Novartis Investigative Site, Bucharest, District 2 Novartis Investigative Site, Bucharest, District 2 Novartis Investigative Site, Bucharest Novartis Investigative Site, Timișoara Spain
Novartis Investigative Site, Granada, Andalusia Novartis Investigative Site, Palma, Balearic Islands Novartis Investigative Site, Barcelona Novartis Investigative Site, Granollers Novartis Investigative Site, Las Palmas GC Novartis Investigative Site, Madrid Novartis Investigative Site, Madrid Novartis Investigative Site, Pontevedra Novartis Investigative Site, Seville Novartis Investigative Site, Valencia Turkey (Türkiye)
Novartis Investigative Site, Izmir, Balcova Novartis Investigative Site, Ankara, Bilkent-Cankaya Novartis Investigative Site, Izmir, Buca Novartis Investigative Site, Aydin, Efeler Novartis Investigative Site, Denizli, Kinikli Novartis Investigative Site, Ankara, Sihhiye-Altindag Novartis Investigative Site, Ankara, Yenimahalle Novartis Investigative Site, Mersin, Yenisehir Novartis Investigative Site, Izmir Novartis Investigative Site, Kecioren Ankara United Kingdom
Novartis Investigative Site, Leeds, West Yorkshire Novartis Investigative Site, Bristol Novartis Investigative Site, Cardiff Novartis Investigative Site, London Novartis Investigative Site, London Novartis Investigative Site, London Novartis Investigative Site, Southampton
Key details Sponsor
Novartis Pharmaceuticals
Enrollment target
~555 participants
Primary completion
October 2027
Age range
12 Years – 100 Years
Last updated March 2026
Interested in joining? Novartis Investigative Site, Minden
Novartis Investigative Site, München Novartis Investigative Site, Tübingen